欧洲转染试剂和设备市场预测至 2030 年 - 区域分析 - 按产品(试剂和仪器)、方法(病毒方法、非病毒方法和混合方法)、应用(生物医学研究、蛋白质生产和治疗递送)和最终用户(学术和研究机构以及制药和生物技术公司)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030


No. of Pages: 112    |    Report Code: BMIRE00030436    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Transfection Reagents and Equipment Market
2022 年欧洲转染试剂和设备市场价值为 3.0604 亿美元,预计到 2030 年将达到 5.5546 亿美元;预计 2022 年至 2030 年的复合年增长率为 7.7%。

公司战略举措推动欧洲转染试剂和设备市场

转染是开发病毒载体整个过程中的复杂步骤,包括腺病毒、腺相关病毒和慢病毒。随着制造工艺的扩大,瞬时转染也必须增加。工艺设备供应商、药物开发商和原材料供应商正致力于合作开发具有成本效益、实用且可平台化的解决方案,以快速开发和扩大病毒载体制造工艺。在小规模上,通过计划的材料量和转移与混合时间,用多个质粒转染细胞变得可行。扩大规模需要工业化转染步骤的经验,因为大多数公司仅在实验室层面拥有转染经验。然而,将工艺扩大到更大规模所需的细胞培养基和转染试剂的数量可能不切实际,这强调了优化的必要性。尽管如此,近年来,随着对病毒载体的需求激增,扩大生产规模已变得很普遍。由于大规模转染工艺面临诸多挑战,提高产量的最佳方法是缩短工艺而不是扩大工艺。这种自上而下的方法可以清楚地识别在工业层面影响工艺的条件,例如转染复合溶液的量。这种方法还有助于工艺优化和决策。开发此类方法来加速小规模转染工艺,为欧洲转染试剂和设备市场的增长提供了机会。

欧洲转染试剂和设备市场概览

欧洲地区分为英国、德国、法国、西班牙、意大利和欧洲其他地区。英国在 2022 年拥有最大的市场份额。制药行业的增长取决于该国正在进行的高质量研发以及广泛而蓬勃发展的医疗保健知识库。英国是世界上研究、开发、制造、临床采用和先进疗法报销的最佳生态系统之一。目前,英国正在进行 85 多项临床试验,70 家 CGT 公司正在努力开发潜在的治愈疗法。Catapult 是一家为英国 CGT 生态系统做出重大贡献的顶级公司;它是该国参与开发试剂和设备制造工艺的前五大公司之一。该公司专注于开发更智能的自动化 CGT 制造工艺,可以自动适应不断变化的环境和工艺要求,同时只需最少的干预。因此,英国公司为提高生产力和降低最终产品成本所做的努力是推动英国细胞和基因治疗市场增长的主要因素。此外,由于英国持续和有针对性地投资研究,英国在欧洲细胞和基因治疗市场占据强势地位,这进一步使市场受益。

此外,法国拥有赛诺菲、益普生、皮埃尔法伯、HRA Pharma 和 TxCell(Sangamo Therapeutics,Inc.)等生物制药和制药巨头。这些公司参与疫苗和抗体等的开发,其产品需要冻干,这增加了对转染试剂和设备的需求。

欧洲转染试剂和设备市场收入及预测至 2030 年(百万美元)

欧洲转染试剂和设备市场细分

欧洲转染试剂和设备市场根据产品、方法、应用、最终用户和国家/地区进行细分。

根据产品,欧洲转染试剂和设备市场分为试剂和仪器。试剂部分在 2022 年占有较大的份额。

就方法而言,欧洲转染试剂和设备市场细分为病毒方法、非病毒方法和混合方法。非病毒方法部分在 2022 年占有最大份额。病毒部分细分为逆转录病毒、腺病毒、腺相关病毒和疱疹病毒。非病毒部分分为物理/机械方法和化学方法。此外,物理/机械方法部分细分为电穿孔、显微注射、基因枪法、激光法、磁转染和声穿孔。此外,化学方法部分细分为基于脂质体/高脂质和非基于脂质体/高脂质。

根据应用,欧洲转染试剂和设备市场细分为生物医学研究、蛋白质生产和治疗输送。 2022 年,生物医学研究领域占有最大份额。

根据最终用户,欧洲转染试剂和设备市场分为学术和研究机构以及制药和生物技术公司。2022 年,学术和研究机构部门占有较大份额。

根据国家/地区,欧洲转染试剂和设备市场分为德国、法国、英国、意大利、西班牙和欧洲其他地区。2022 年,英国在欧洲转染试剂和设备市场占据主导地位。

Fisher Scientific Inc、Promega Corp、F. Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc、Mirus Bio LLC、QIAGEN NV、Merck KGaA、Lonza Group AG、MaxCyte Inc 和 Polyplus-Transfection SA 是欧洲转染试剂和设备市场的一些领先公司。

Europe Transfection Reagents and Equipment Strategic Insights

Strategic insights for Europe Transfection Reagents and Equipment involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/europe-transfection-reagents-and-equipment-market-strategic-framework.webp
Get more information on this report

Europe Transfection Reagents and Equipment Report Scope

Report Attribute Details
Market size in 2022 US$ 306.04 Million
Market Size by 2030 US$ 555.46 Million
Global CAGR (2022 - 2030) 7.7%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 产品
  • 试剂及仪器
By 方法
  • 病毒方法
  • 非病毒方法
  • 混合方法
By 最终用户
  • 学术机构
  • 研究机构以及制药和生物技术公司
Regions and Countries Covered 欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
Market leaders and key company profiles
  • Thermo Fisher Scientific Inc
  • Promega Corp
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Mirus Bio LLC
  • QIAGEN NV
  • Merck KGaA
  • Lonza Group AG
  • MaxCyte Inc
  • Polyplus-Transfection SA
  • Get more information on this report

    Europe Transfection Reagents and Equipment Regional Insights

    The regional scope of Europe Transfection Reagents and Equipment refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-transfection-reagents-and-equipment-market-geography.webp
    Get more information on this report

    The List of Companies - Europe Transfection Reagents and Equipment Market

    1. Thermo Fisher Scientific Inc
    2. Promega Corp
    3. F. Hoffmann-La Roche Ltd
    4. Bio-Rad Laboratories Inc
    5. Mirus Bio LLC
    6. QIAGEN NV
    7. Merck KGaA
    8. Lonza Group AG
    9. MaxCyte Inc
    10. Polyplus-Transfection SA

    Frequently Asked Questions
    How big is the Europe Transfection Reagents and Equipment Market?

    The Europe Transfection Reagents and Equipment Market is valued at US$ 306.04 Million in 2022, it is projected to reach US$ 555.46 Million by 2030.

    What is the CAGR for Europe Transfection Reagents and Equipment Market by (2022 - 2030)?

    As per our report Europe Transfection Reagents and Equipment Market, the market size is valued at US$ 306.04 Million in 2022, projecting it to reach US$ 555.46 Million by 2030. This translates to a CAGR of approximately 7.7% during the forecast period.

    What segments are covered in this report?

    The Europe Transfection Reagents and Equipment Market report typically cover these key segments-

  • 产品 (试剂及仪器)
  • 方法 (病毒方法, 非病毒方法, 混合方法)
  • 最终用户 (学术机构, 研究机构以及制药和生物技术公司)
  • What is the historic period, base year, and forecast period taken for Europe Transfection Reagents and Equipment Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Transfection Reagents and Equipment Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in Europe Transfection Reagents and Equipment Market?

    The Europe Transfection Reagents and Equipment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Thermo Fisher Scientific Inc
  • Promega Corp
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Mirus Bio LLC
  • QIAGEN NV
  • Merck KGaA
  • Lonza Group AG
  • MaxCyte Inc
  • Polyplus-Transfection SA
  • Who should buy this report?

    The Europe Transfection Reagents and Equipment Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Transfection Reagents and Equipment Market value chain can benefit from the information contained in a comprehensive market report.